Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0011 | 1 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |